Katherine Croswell is an associate in Winston & Strawn’s litigation department. She concentrates her practice in patent litigation, with a focus on pharmaceutical patent litigation under the Hatch-Waxman Act. Ms. Croswell has been involved in all aspects of the pre-trial, trial, and post-trial phases of patent infringement cases, including drafting extensive pre-trial and post-trial briefs. She has also drafted an assortment of briefs and other filings for submission to a variety of federal courts. Ms. Croswell has represented several pharmaceutical clients, including Teva, Sandoz, Watson, Anchen and Sun Pharmaceuticals. She has worked on various drugs and drug products, including Lidoderm®, Veramyst®, Dexilant®, Seroquel XR®, Nexium® I.V., Entocort® and argatroban.
In addition to pharmaceutical patent litigation, Ms. Croswell’s experience includes representation of clients such as Dell, Shuffle Master and FieldTurf Tarkett in various patent litigation matters. Ms. Croswell also has experience in white collar criminal defense, appellate work and employment matters.
Before joining the firm in 2010, Ms. Croswell served as a post-graduate judicial intern to the Honorable James F. Holderman, Chief Judge of the United States District Court for the Northern District of Illinois.
Ms. Croswell’s pro bono and non-profit work includes serving as a guardian ad litem in Illinois state court and assisting with a contract dispute involving two Chicago museums.
Ms. Croswell received a B.A. in Criminology and a B.S. in Psychology, both degrees cum laude, from the University of Florida in 2005. She received a J.D., magna cum laude, in 2009 from the University Of Illinois College Of Law, where she was a notes editor of the Illinois Journal of Law, Technology and Policy.